Key result
Hospital readmission fails to reliably reflect surgical quality or mortality in ovarian cancer.
Why the study?
The role of 30-day readmission rate as a quality of care metric in patients undergoing ovarian cancer surgery was unclear.
Observational
No takes yet. Share an insight, caveat, or question.
30-day readmission may misclassify high-volume centers; challenges its validity as a standalone quality metric in ovarian cancer surgery.
Uppal et al. (2018) conducted an observational in Ovarian Cancer. Hospital readmission vs. Other quality of care metrics was evaluated on Comparative performance of risk-adjusted 30-day readmission rate to 30- and 90-day mortality and adherence to NCCN guidelines. Hospital readmission serves as a poor measure of quality in ovarian cancer surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: